| Identification | Back Directory | [Name]
1-(1-Methylethyl)-3-(2-naphthalenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | [CAS]
1092788-23-2 | [Synonyms]
CpCDPK1/TgCDPK1-IN-1
1-(1-Methylethyl)-3-(2-naphthalenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | [Molecular Formula]
C18H17N5 | [MOL File]
1092788-23-2.mol | [Molecular Weight]
303.36 |
| Hazard Information | Back Directory | [Uses]
CpCDPK1/TgCDPK1-IN-1 (compound 7p) is a potent CpCDPK1/TgCDPK1 dual inhibitor (IC50: 10 nM and 5.0 nM respectively). CpCDPK1/TgCDPK1-IN-1 also inhibits Abl and Src (IC50: 75 nM and 65 nM respectively). CpCDPK1/TgCDPK1-IN-1 can be used for research of toxoplasmosis[1]. | [References]
[1] Wesley C. Van Voorhis, et al. Compositions And Methods For Treating Toxoplasmosis, Cryptosporidiosis, And Other Apicomplexan Protozoan Related Diseases. Patent. US20130018040. |
|
|